Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS transition

This article was originally published in The Gray Sheet

Executive Summary

Members of President-elect Clinton's transition team "cluster" with responsibility for HHS met with Secretary-designate Donna Shalala, PhD, Dec. 27-28 to discuss pending and future issues to be addressed by the department when she takes office. Many of the HHS cluster group personnel have completed their transition work and returned to Capitol Hill to resume congressional staff duties. Shalala reportedly plans to appoint a special liaison to FDA....

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000013

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel